`Filed: February 11, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., and MYLAN INC.,
`Petitioner,
`
`v .
`
`SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.
`Patent Owner.
`__________________
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`__________________
`
`PETITIONER’S AMENDED NOTICE OF CROSS-EXAMINATION OF
`DR. ADAM C. MYERS, Ph.D.
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`
`Pursuant to 37 C.F.R. § 42.53, Petitioners INNOPHARMA LICENSING,
`
`INC.,
`
`INNOPHARMA
`
`LICENSING
`
`LLC,
`
`INNOPHARMA
`
`INC.,
`
`INNOPHARMA LLC, MYLAN PHARMACEUTICALS INC., and MYLAN
`
`INC., (“Petitioner” or “InnoPharma”), by and through its attorneys, will conduct a
`
`cross-examination by deposition of Dr. Adam C. Myers, Ph.D. regarding his
`
`declaration submitted in IPR2015-00902. Dr. Myers’ cross-examination will take
`
`place, as agreed by counsel for the parties, on February 24, 2016, commencing at
`
`9:00 a.m. (local time), at the offices of Finnegan, Henderson, Farabow, Garrett &
`
`Dunner, LLP, 901 New York Avenue, NW, Washington, DC 20001-4413.
`
`Counsel for Patent Owner has represented that Dr. Myers is willing to appear at the
`
`time and location indicated above.
`
`The cross-examination will take place before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded using at least audiotape
`
`and/or stenographic means.
`
`InnoPharma also intends to video record the cross-
`
`examination of Dr. Myers. The arrangements for the reporter and videographer
`
`will be made by counsel for Petitioners.
`
`Date: February 11, 2016
`
`/Jitendra Malik/
`
`Jitendra Malik (Reg. No. 55823)
`Alston & Bird LLP
`4721 Emperor Boulevard, Suite 400
`Durham, North Carolina 27703
`
`1
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`
`Telephone: 919-862-2200
`Fax: 919-862-2260
`Jitty.Malik@alston.com
`
`Lead Counsel for Petitioner
`InnoPharma Licensing Inc., InnoPharma
`Licensing LLC, InnoPharma Inc.,
`InnoPharma LLC, Mylan
`Pharmaceuticals Inc., and Mylan Inc.
`
`2
`
`
`
`CERTIFICATION OF SERVICE
`The undersigned certifies that on the 11th day of February, 2016, a copy of
`
`the foregoing Petitioner’s Notice of Cross-Examination of Dr. Adam C. Myers,
`
`Ph.D. was served via email directed to counsel of record for the Patent Owner at
`
`the following:
`
`Bryan C. Diner
`bryan.diner@finnegan.com
`
`Justin J. Hasford
`justin.hasford@finnegan.com
`
`Joshua L. Goldberg
`Joshua.goldberg@finnegan.com
`
`Respectfully submitted,
`
`Alston & Bird LLP
`
`By: /Jitendra Malik/
`
`Jitendra Malik, Ph.D.
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Reg. No. 50893
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`bryan.skelton@alston.com
`
`Lance Soderstrom
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`
`Reg. No. 65405
`Alston & Bird LLP
`90 Park Avenue
`15th Floor
`New York, NY 10016-1387
`lance.soderstrom@alston.com
`
`Hidetada James Abe
`Reg. No. 61,182
`Alston & Bird LLP
`333 South Hope Street
`16th Floor
`Los Angeles, CA 90071
`james.abe@alston.com
`
`Attorneys for Petitioners InnoPharma
`Licensing, Inc., InnoPharma Licensing LLC,
`InnoPharma Inc., InnoPharma LLC, Mylan
`Pharmaceuticals Inc., and Mylan Inc.
`
`2